ArticleHealth systems (Basingstoke, England)2026
Generative AI models for type 2 diabetes mellitus risk prediction.
Article in Health systems (Basingstoke, England), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Diabetes, precisely Type II Diabetes Mellitus (T2DM), is a prevalent global chronic condition. This study focuses on improving the accuracy of predicting T2DM onset and risk by utilizing Generative Artificial Intelligence (GenAI) based synthetic data generation and innovative feature selection techniques. GenAI models such as Deep Tabular Augmentation (DTA) and Large Language Models (LLM) were utilized to address class imbalance and data scarcity of diabetes class for prediction. The Representative Instances-based Fuzzy Rough Set Feature Selection (FRS-RI) method was employed for optimal feature selection. Three diabetes datasets - Sylhet, Obesity, and Diagnostic Features - were employed. After FRS-RI feature selection and synthetic data generation, Machine Learning (ML), Ensemble Learning (EL), and Deep Learning (DL) models were trained on these datasets. The ML, EL, and DL models achieved impressive accuracy, precision, and recall scores: 95.19%, 0.96, and 0.94 for the Sylhet Dataset; 100%, 1.00, and 1.00 for the Obesity dataset; and 97.44%, 0.97, and 0.94 for the NIDDK-DF Dataset. The model's ability to generalize to new diabetic data was demonstrated by enhanced test accuracies of 98.37% and 97.33% obtained when the suggested techniques were applied to benchmark datasets such as PIMA and LMCH, respectively. Emphasis was also placed on model explainability to justify predictions for clinical presentation.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.